The biotech sector has been a disaster for investors over the past five years going by a 14% decline compared to an 86% gain ...
7don MSNOpinion
Turmoil at the FDA Threatens Biotech Recovery
Unexpected delays, infighting and a staffing crisis are fueling investors’ unease.
Data demonstrates the significant and sustained tumor regression achieved by the CAPTN-3 platform across two distinct tri-specific antibodies, IM1240 and IM1305, targeting different tumor antigens ...
Discover how the Impact of R&D on Biotech Companies in India is driving innovation, boosting exports and transforming pharma, ...
Study points to source of "very, very rare" cases of myocarditis and potential solutions. Myocarditis risk remains far higher ...
A decades-old way to bridge buyers and sellers on price, contingent value rights have recently seen an uptick in use due to a ...
The EU Bioeconomy strategy touches on both sustainable packaging materials and novel foods. The strategy procedes the ...
Praxis Precision Medicines Inc. (NASDAQ:PRAX) is one of the best biotech stocks to buy according to Wall Street analysts. On ...
Even with a minimum wage of $18.67, San Francisco remains one of the hardest cities to manage on an hourly income. Tech ...
The government had launched the Biopharma Mission at the national level, while other programs included Bio AI Hubs, Bio Agriculture and Bioenergy, Prof. Sopory said while addressing the inaugural ...
Company to Discuss Proposed Amendment to Phase 3 VERSATILE-003 Trial Enabling Potential Accelerated Approval PathwayPRINCETON, N.J., Dec. 02, 2025 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation ...
Acquisition creates additional near-term revenue opportunities from newly formed Contract Development and Manufacturing Organization (CDMO) subsidiary, Velocity Bioworks™ Financing led by 3i, LP ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback